tiprankstipranks
Trending News
More News >
Scopus BioPharma (SCPS)
OTHER OTC:SCPS
US Market

Scopus BioPharma (SCPS) Income Statement

Compare
67 Followers

Scopus BioPharma Income Statement

Last quarter (Q2 2023), Scopus BioPharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Scopus BioPharma's net income was $-2.62M. See Scopus BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.71M$ 27.63M$ 10.16M$ 2.69M$ 685.96K
Depreciation and Amortization
$ 1.73K$ 1.50K$ 1.44K$ 664.00$ 161.14K
EBITDA
$ -11.71M$ -26.18M$ -10.15M$ -2.69M$ -685.96K
Operating Income
$ -11.71M$ -27.63M$ -10.16M$ -2.69M$ -685.96K
Other Income/Expenses
$ 0.00$ 681.21K$ -706.45K$ 0.00$ 0.00
Pretax Income
$ -11.71M$ -26.95M$ -10.86M$ -2.69M$ -685.96K
Net Income
$ -11.61M$ -27.73M$ -11.57M$ -2.69M$ -685.96K
Per Share Metrics
Basic EPS
$ -0.55$ -1.61$ -0.87$ -0.18$ -0.05
Diluted EPS
$ -0.55$ -1.61$ -0.87$ -0.18$ -0.05
Weighted Average Shares Outstanding
21.09M 17.25M 13.36M 14.98M 14.98M
Weighted Average Shares Outstanding (Diluted)
21.09M 17.25M 13.36M 14.98M 14.98M
Currency in USD

Scopus BioPharma Earnings and Revenue History